Search results
Roche (RHHBY) Q1 Revenues Decline on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 1 year agoSwiss pharma giant Roche Holding AG’s RHHBY first-quarter revenues declined 7% to CHF 15.3 billion...
Alicia Witt Reveals She Was Beginning Treatments for Cancer When Her Parents Died
People via Yahoo News· 2 years agoAlicia Witt/instagram Alicia Witt is opening up about her private battle with cancer two months...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 5 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
Roche (RHHBY) Nine Months' Sales Fall on Lower COVID-19 Test Sale
Zacks via Yahoo Finance· 7 months agoRoche (RHHBY) reports a sales decline in the first nine months of 2023 as COVID-19-test sales...
Alicia Witt shows off her growing hair following cancer treatments: ‘I’m honestly feeling pretty...
The Independent via Yahoo News· 1 year agoAlicia Witt has shared some photos of her growing hair after completing rounds of chemotherapy for...
Roche (RHHBY) 2023 Earnings Miss, COVID-19 Product Sales Down
Zacks via Yahoo Finance· 3 months agoRoche (RHHBY) misses earnings and sales estimates in 2023 due to a significant decline in...
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Zacks via Yahoo Finance· 1 week agoRoche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue...
Organon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoOrganon & Co. (NYSE:OGN) Q1 2024 Earnings Call Transcript May 2, 2024 Organon & Co. misses on...
3 Great Foreign Companies to Invest in Right Now
Motley Fool via Yahoo Finance· 4 months agoForeign stocks are underrated investments that could be an important addition to your portfolio. International companies can be a great tool for...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 9 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
